<p>Cryoport, Inc. (NASDAQ:CYRX - 獲取免費報告) 股票在週二的午盤交易中下跌了 6.8%。該公司的股價最低下跌至 10.49 美元，最後交易價為 10.49 美元。在交易過程中，共有 35,269 股股票交易，較平均交易量 473,428 股下降了 93%。該股上一個收盤價為 11.25 美元。</p>
<h2>分析師升級和降級</h2>
<p>一些股票分析師最近發佈了關於該股的報告。Jefferies Financial Group 在 4 月 4 日星期四的研究報告中開始對 Cryoport 的股票進行覆蓋。他們給予該股一個 “買入” 評級，並設定了 21.00 美元的目標價。B. Riley 在 5 月 3 日星期五的研究報告中將 Cryoport 的評級從 “買入” 調降至 “中性”，並將目標股價從 22.00 美元降至 19.00 美元。Stephens 在 3 月 13 日星期三的研究報告中重申了 “等權重” 評級，並設定了 17.00 美元的目標股價。Needham &amp; Company LLC 在 5 月 8 日星期三的報告中重申了 “買入” 評級，並給出了 18.00 美元的目標價。最後，瑞銀集團將 Cryoport 的目標價從 14.50 美元上調至 17.00 美元，並給予該公司一個 “中性” 評級。六位股票研究分析師對該股進行了持有評級，兩位對該股進行了買入評級。根據 MarketBeat 的數據，該股目前的平均評級為 “持有”，平均目標價為 18.25 美元。</p>
<p><strong>閲讀我們對 Cryoport 的最新分析</strong></p>
<h2>Cryoport 股價表現</h2>
<p>該公司的資產負債比為 0.86，流動比率為 10.73，速動比率為 10.22。公司的 50 天簡單移動平均價格為 14.51 美元，200 天簡單移動平均價格為 15.29 美元。該公司的市值為 4.9897 億美元，市盈率為-4.25，貝塔係數為 1.64。</p>
<p>Cryoport (NASDAQ:CYRX - 獲取免費報告) 於 5 月 7 日星期二發佈了最新的財報。該公司報告季度每股收益為（0.43）美元，低於市場預期的（0.37）美元。該季度公司營收為 5459 萬美元，低於分析師預期的 5878 萬美元。Cryoport 的淨利潤率為-50.17%，淨資產回報率為-15.19%。該季度的營收較去年同期下降了 13.1%。去年同期，該公司每股虧損為（0.16）美元。平均而言，股票研究分析師預計 Cryoport, Inc.今年將實現-1.35 美元的每股收益。</p>
<h2>內部人員活動</h2>
<p>在相關消息中，首席執行官 Jerrell Shelton 於 3 月 15 日星期五出售了 Cryoport 股票的 57,039 股。股票的平均售價為 15.30 美元，總交易額為 872,696.70 美元。交易完成後，首席執行官現在直接持有公司股票 634,352 股，價值 9,705,585.60 美元。該交易已在提交給證券交易委員會的文件中披露，可通過此鏈接獲得。此外，董事 Richard J. Berman 於 5 月 15 日星期三出售了公司股票 8,105 股。股票的平均售價為 13.41 美元，總價值為 108,688.05 美元。交易完成後，該董事現在直接持有公司股票 100,000 股，價值約 1,341,000 美元。該銷售已在提交給證券交易委員會的文件中披露，可通過此鏈接訪問。此外，首席執行官 Jerrell Shelton 於 3 月 15 日星期五出售了 Cryoport 股票的 57,039 股。股票的平均售價為 15.30 美元，總價值為 872,696.70 美元。交易完成後，首席執行官現在直接持有公司 634,352 股股票，價值 9,705,585.60 美元。有關此次交易的披露信息可在此處找到。過去 90 天內，內部人員已出售了價值 1,199,908 美元的公司股票 79,228 股。公司內部人員持有公司股份的比例為 10.10%。</p>
<h2>機構資金流入和流出</h2>
<p>機構投資者最近增加或減少了他們在該公司的持股。Comerica Bank 在第一季度將其在 Cryoport 的持股增加了 73.0%。Comerica Bank 現在擁有 3,481 股該公司股票，價值 62,000 美元，在此期間增加了 1,469 股。Natixis Investment Managers International 在第四季度將其在 Cryoport 的持股增加了 61.5%。Natixis Investment Managers International 現在擁有 4,536 股該公司股票，價值 70,000 美元，在此期間增加了 1,727 股。Lazard Asset Management LLC 在第一季度將其在 Cryoport 的持股增加了 294.3%。Lazard Asset Management LLC 現在擁有 5,378 股該公司股票，價值 95,000 美元，在此期間增加了 4,014 股。WINTON GROUP Ltd 在第三季度購入了 Cryoport 的新頭寸，價值約 163,000 美元。最後，Pathstone Family Office LLC 在第三季度購入了 Cryoport 的新頭寸，價值約 165,000 美元。該股 92.90% 的股份由機構投資者持有。</p>
<h2>Cryoport 公司簡介（獲取免費報告）</h2>
<p>Cryoport, Inc.在美洲、歐洲、中東、非洲和亞太地區的生物製藥/製藥、動物健康和人類生殖醫學市場提供温控供應鏈解決方案。該公司提供 Cryoport Express 運輸箱；Cryoport ELITE -80°C 基因療法運輸箱；Cryoport ELITE Cryosphere 運輸箱；Cryoport 諮詢服務，包括運輸系統和/或包裝的物理、熱力學和資格認證，以開發定製包裝解決方案；以及 Cryoport 生物服務，如受控温度存儲、配送、套件生產、治療產品標籤、GMP 原材料存儲等服務。</p>
<h2>精選文章</h2>
<ul>
<li>五支我們比 Cryoport 更喜歡的股票</li>
<li>能源和石油股票解析</li>
<li>三支強勁分析師評級的高收益股</li>
<li>房地產投資信託在您的投資組合中應該佔據一席之地嗎？</li>
<li>三支值得關注的股票：芯片短缺對行業的影響</li>
<li>市值計算器：如何計算市值</li>
<li>股息王 ABM Industries 正朝着新高邁進</li>
</ul>
<p><em>這則即時新聞警報是由敍事科技和來自 MarketBeat 的金融數據生成，旨在為讀者提供最快速和最準確的報道。本故事在發佈之前已經經過 MarketBeat 編輯團隊的審核。請將有關本故事的任何問題或評論發送至 contact@marketbeat.com。</em></p>
<p>→ 正在進行史上最大規模的合法財富轉移（來自 Stansberry Research）(廣告)</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD04MzA2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD04MzA2"/></p>
<h2>現在是否值得投資$1,000 在 Cryoport？</h2>
<p>在考慮 Cryoport 之前，您需要聽到這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂尖和表現最佳的研究分析師以及他們向客户推薦的股票。MarketBeat 已經確定了五支頂尖分析師悄悄告訴他們的客户現在購買的股票清單...而 Cryoport 並不在其中。</p>
<p>雖然 Cryoport 目前在分析師中有一個 “持有” 評級，但頂尖分析師認為這五支股票更值得購買。</p>
<p>查看這五支股票</p>

CYRX

<p>Cryoport（納斯達克股票代碼：CYRX）股票在午盤交易中下跌了 6.8%。分析師們發佈了關於該股的報告，平均評級為 “持有”，平均目標股價為 18.25 美元。該公司報告顯示季度盈利低於預期。內部人士已經大量拋售公司股票。機構投資者已對其持股進行了調整</p>

<p>Cryoport, Inc. (NASDAQ:CYRX - Get Free Report) shares traded down 6.8% during mid-day trading on Tuesday . The company traded as low as $10.49 and last traded at $10.49. 35,269 shares were traded during trading, a decline of 93% from the average session volume of 473,428 shares. The stock had previously closed at $11.25.</p>
<div class="lb-trans"><p>Cryoport, Inc. (NASDAQ:CYRX - 獲取免費報告) 股票在週二的午盤交易中下跌了 6.8%。該公司的股價最低下跌至 10.49 美元，最後交易價為 10.49 美元。在交易過程中，共有 35,269 股股票交易，較平均交易量 473,428 股下降了 93%。該股上一個收盤價為 11.25 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師升級和降級</h2>
</div><p>A number of equities analysts have recently issued reports on the stock. Jefferies Financial Group began coverage on shares of Cryoport in a research report on Thursday, April 4th. They set a &#34;buy&#34; rating and a $21.00 target price on the stock. B. Riley downgraded Cryoport from a &#34;buy&#34; rating to a &#34;neutral&#34; rating and cut their price target for the stock from $22.00 to $19.00 in a research note on Friday, May 3rd. Stephens reaffirmed an &#34;equal weight&#34; rating and set a $17.00 price target on shares of Cryoport in a research note on Wednesday, March 13th. Needham &amp; Company LLC restated a &#34;buy&#34; rating and issued a $18.00 target price on shares of Cryoport in a report on Wednesday, May 8th. Finally, UBS Group upped their target price on shares of Cryoport from $14.50 to $17.00 and gave the company a &#34;neutral&#34; rating in a report on Friday, March 15th. Six equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of &#34;Hold&#34; and an average target price of $18.25.</p>
<div class="lb-trans"><p>一些股票分析師最近發佈了關於該股的報告。Jefferies Financial Group 在 4 月 4 日星期四的研究報告中開始對 Cryoport 的股票進行覆蓋。他們給予該股一個 “買入” 評級，並設定了 21.00 美元的目標價。B. Riley 在 5 月 3 日星期五的研究報告中將 Cryoport 的評級從 “買入” 調降至 “中性”，並將目標股價從 22.00 美元降至 19.00 美元。Stephens 在 3 月 13 日星期三的研究報告中重申了 “等權重” 評級，並設定了 17.00 美元的目標股價。Needham &amp; Company LLC 在 5 月 8 日星期三的報告中重申了 “買入” 評級，並給出了 18.00 美元的目標價。最後，瑞銀集團將 Cryoport 的目標價從 14.50 美元上調至 17.00 美元，並給予該公司一個 “中性” 評級。六位股票研究分析師對該股進行了持有評級，兩位對該股進行了買入評級。根據 MarketBeat 的數據，該股目前的平均評級為 “持有”，平均目標價為 18.25 美元。</p>
</div><p><strong>Read Our Latest Analysis on Cryoport</strong></p>
<div class="lb-trans"><p><strong>閲讀我們對 Cryoport 的最新分析</strong></p>
</div><h2>Cryoport Price Performance</h2>
<div class="lb-trans"><h2>Cryoport 股價表現</h2>
</div><p>The company has a debt-to-equity ratio of 0.86, a current ratio of 10.73 and a quick ratio of 10.22. The company's 50-day simple moving average is $14.51 and its 200-day simple moving average is $15.29. The company has a market cap of $498.97 million, a price-to-earnings ratio of -4.25 and a beta of 1.64.</p>
<div class="lb-trans"><p>該公司的資產負債比為 0.86，流動比率為 10.73，速動比率為 10.22。公司的 50 天簡單移動平均價格為 14.51 美元，200 天簡單移動平均價格為 15.29 美元。該公司的市值為 4.9897 億美元，市盈率為-4.25，貝塔係數為 1.64。</p>
</div><p>Cryoport (NASDAQ:CYRX - Get Free Report) last released its earnings results on Tuesday, May 7th. The company reported ($0.43) EPS for the quarter, missing the consensus estimate of ($0.37) by ($0.06). The business had revenue of $54.59 million for the quarter, compared to analysts' expectations of $58.78 million. Cryoport had a negative net margin of 50.17% and a negative return on equity of 15.19%. The business's quarterly revenue was down 13.1% compared to the same quarter last year. During the same quarter last year, the company posted ($0.16) earnings per share. On average, equities research analysts anticipate that Cryoport, Inc. will post -1.35 EPS for the current year.</p>
<div class="lb-trans"><p>Cryoport (NASDAQ:CYRX - 獲取免費報告) 於 5 月 7 日星期二發佈了最新的財報。該公司報告季度每股收益為（0.43）美元，低於市場預期的（0.37）美元。該季度公司營收為 5459 萬美元，低於分析師預期的 5878 萬美元。Cryoport 的淨利潤率為-50.17%，淨資產回報率為-15.19%。該季度的營收較去年同期下降了 13.1%。去年同期，該公司每股虧損為（0.16）美元。平均而言，股票研究分析師預計 Cryoport, Inc.今年將實現-1.35 美元的每股收益。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>內部人員活動</h2>
</div><p>In related news, CEO Jerrell Shelton sold 57,039 shares of Cryoport stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $15.30, for a total transaction of $872,696.70. Following the transaction, the chief executive officer now directly owns 634,352 shares of the company's stock, valued at $9,705,585.60. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, Director Richard J. Berman sold 8,105 shares of the firm's stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $13.41, for a total value of $108,688.05. Following the transaction, the director now directly owns 100,000 shares of the company's stock, valued at approximately $1,341,000. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jerrell Shelton sold 57,039 shares of Cryoport stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $15.30, for a total value of $872,696.70. Following the completion of the transaction, the chief executive officer now directly owns 634,352 shares in the company, valued at $9,705,585.60. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 79,228 shares of company stock valued at $1,199,908. Company insiders own 10.10% of the company's stock.</p>
<div class="lb-trans"><p>在相關消息中，首席執行官 Jerrell Shelton 於 3 月 15 日星期五出售了 Cryoport 股票的 57,039 股。股票的平均售價為 15.30 美元，總交易額為 872,696.70 美元。交易完成後，首席執行官現在直接持有公司股票 634,352 股，價值 9,705,585.60 美元。該交易已在提交給證券交易委員會的文件中披露，可通過此鏈接獲得。此外，董事 Richard J. Berman 於 5 月 15 日星期三出售了公司股票 8,105 股。股票的平均售價為 13.41 美元，總價值為 108,688.05 美元。交易完成後，該董事現在直接持有公司股票 100,000 股，價值約 1,341,000 美元。該銷售已在提交給證券交易委員會的文件中披露，可通過此鏈接訪問。此外，首席執行官 Jerrell Shelton 於 3 月 15 日星期五出售了 Cryoport 股票的 57,039 股。股票的平均售價為 15.30 美元，總價值為 872,696.70 美元。交易完成後，首席執行官現在直接持有公司 634,352 股股票，價值 9,705,585.60 美元。有關此次交易的披露信息可在此處找到。過去 90 天內，內部人員已出售了價值 1,199,908 美元的公司股票 79,228 股。公司內部人員持有公司股份的比例為 10.10%。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>Institutional investors have recently added to or reduced their stakes in the business. Comerica Bank increased its position in Cryoport by 73.0% in the 1st quarter. Comerica Bank now owns 3,481 shares of the company's stock worth $62,000 after buying an additional 1,469 shares during the period. Natixis Investment Managers International increased its position in Cryoport by 61.5% in the 4th quarter. Natixis Investment Managers International now owns 4,536 shares of the company's stock worth $70,000 after buying an additional 1,727 shares during the period. Lazard Asset Management LLC increased its position in Cryoport by 294.3% in the 1st quarter. Lazard Asset Management LLC now owns 5,378 shares of the company's stock worth $95,000 after buying an additional 4,014 shares during the period. WINTON GROUP Ltd bought a new position in Cryoport in the 3rd quarter worth approximately $163,000. Finally, Pathstone Family Office LLC bought a new position in Cryoport in the 3rd quarter worth approximately $165,000. 92.90% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>機構投資者最近增加或減少了他們在該公司的持股。Comerica Bank 在第一季度將其在 Cryoport 的持股增加了 73.0%。Comerica Bank 現在擁有 3,481 股該公司股票，價值 62,000 美元，在此期間增加了 1,469 股。Natixis Investment Managers International 在第四季度將其在 Cryoport 的持股增加了 61.5%。Natixis Investment Managers International 現在擁有 4,536 股該公司股票，價值 70,000 美元，在此期間增加了 1,727 股。Lazard Asset Management LLC 在第一季度將其在 Cryoport 的持股增加了 294.3%。Lazard Asset Management LLC 現在擁有 5,378 股該公司股票，價值 95,000 美元，在此期間增加了 4,014 股。WINTON GROUP Ltd 在第三季度購入了 Cryoport 的新頭寸，價值約 163,000 美元。最後，Pathstone Family Office LLC 在第三季度購入了 Cryoport 的新頭寸，價值約 165,000 美元。該股 92.90% 的股份由機構投資者持有。</p>
</div><h2>Cryoport Company Profile (Get Free Report)</h2>
<div class="lb-trans"><h2>Cryoport 公司簡介（獲取免費報告）</h2>
</div><p>Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.</p>
<div class="lb-trans"><p>Cryoport, Inc.在美洲、歐洲、中東、非洲和亞太地區的生物製藥/製藥、動物健康和人類生殖醫學市場提供温控供應鏈解決方案。該公司提供 Cryoport Express 運輸箱；Cryoport ELITE -80°C 基因療法運輸箱；Cryoport ELITE Cryosphere 運輸箱；Cryoport 諮詢服務，包括運輸系統和/或包裝的物理、熱力學和資格認證，以開發定製包裝解決方案；以及 Cryoport 生物服務，如受控温度存儲、配送、套件生產、治療產品標籤、GMP 原材料存儲等服務。</p>
</div><h2>Featured Articles</h2>
<ul>
<li>Five stocks we like better than Cryoport</li>
<li>Energy and Oil Stocks Explained</li>
<li>Top 3 High-Yield Stocks with Strong Analyst Ratings</li>
<li>Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?</li>
<li>3 Stocks to Watch: Chip Shortage Impact on Industries</li>
<li>Market Cap Calculator: How to Calculate Market Cap</li>
<li>Dividend King ABM Industries is on Track for New Highs</li>
</ul>
<div class="lb-trans"><h2>精選文章</h2>
<ul>
<li>五支我們比 Cryoport 更喜歡的股票</li>
<li>能源和石油股票解析</li>
<li>三支強勁分析師評級的高收益股</li>
<li>房地產投資信託在您的投資組合中應該佔據一席之地嗎？</li>
<li>三支值得關注的股票：芯片短缺對行業的影響</li>
<li>市值計算器：如何計算市值</li>
<li>股息王 ABM Industries 正朝着新高邁進</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>這則即時新聞警報是由敍事科技和來自 MarketBeat 的金融數據生成，旨在為讀者提供最快速和最準確的報道。本故事在發佈之前已經經過 MarketBeat 編輯團隊的審核。請將有關本故事的任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><p>→ The Greatest LEGAL Transfer of Wealth in History is Underway (From Stansberry Research)(Ad)</p>
<div class="lb-trans"><p>→ 正在進行史上最大規模的合法財富轉移（來自 Stansberry Research）(廣告)</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD04MzA2" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8306&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in Cryoport right now?</h2>
<div class="lb-trans"><h2>現在是否值得投資$1,000 在 Cryoport？</h2>
</div><p>Before you consider Cryoport, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Cryoport 之前，您需要聽到這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cryoport wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂尖和表現最佳的研究分析師以及他們向客户推薦的股票。MarketBeat 已經確定了五支頂尖分析師悄悄告訴他們的客户現在購買的股票清單...而 Cryoport 並不在其中。</p>
</div><p>While Cryoport currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Cryoport 目前在分析師中有一個 “持有” 評級，但頂尖分析師認為這五支股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五支股票</p>
</div>

Cryoport（納斯達克代碼：CYRX）股價下跌 6.8%